Cite
HARVARD Citation
Hernandez, D. et al. (2016). Impact of Pre-existing NS5A-L31 or -Y93H Minor Variants on Response Rates in Patients Infected with HCV Genotype-1b Treated with Daclatasvir/Asunaprevir. Advances in therapy. 33 (7), pp. 1169-1179. [Online].